Prescription ·Strong evidence ·Reviewed May 2026
Salmeterol/fluticasone combines an inhaled corticosteroid with a long-acting beta-2 agonist for maintenance treatment of asthma and chronic obstructive pulmonary disease. It is not a rescue inhaler, and patients should not use extra LABA therapy; the main safety concerns include serious asthma-related events with LABA monotherapy, pneumonia in COPD, oral candidiasis, adrenal suppression, bone effects, paradoxical bronchospasm, tachyarrhythmia, and hypokalemia.
The bottom line
Evidence rating strong. Most-documented uses: maintenance control of asthma in patients needing inhaled corticosteroid plus laba therapy, reduction of copd symptoms and exacerbations in appropriate patients, improved lung function and reduced rescue inhaler use. 4 sources indexed (2006–2026), with 4 interaction records on file.
Core mechanism
Fluticasone activates glucocorticoid receptors in airway tissues, suppressing inflammatory cytokines, eosinophils, edema, and mucus production. Salmeterol selectively stimulates beta-2 receptors on airway smooth muscle through a long side-chain interaction, increasing cyclic AMP and producing prolonged bronchodilation. The combination addresses both inflammation and bronchoconstriction, but salmeterol must not be used without anti-inflammatory controller therapy in asthma.1,4
Inhaled administration is independent of meals. Rinse mouth and spit after use to reduce oral candidiasis. Use consistently twice daily and keep a short-acting rescue bronchodilator available for acute symptoms.
Beta-2 agonists can lower serum potassium at high exposure, and correcting true hypokalemia reduces arrhythmia risk.
Recommendation: Do not self-treat potassium abnormalities; monitor potassium when high-dose beta-agonists, diuretics, or acute illness are present.
Magnesium repletion can support normal airway and cardiac physiology when deficiency is present.
Recommendation: Use magnesium to correct documented or likely deficiency, not as a replacement for controller or rescue inhaler therapy.
Caffeinated green tea extract may add to salmeterol-related tremor, palpitations, and insomnia.
Recommendation: Avoid high-caffeine extracts if tremor, tachycardia, anxiety, or poor sleep occurs.
St. John's Wort can induce CYP3A4 and may lower exposure to CYP3A4 substrates, potentially making controller response less predictable.
Recommendation: Avoid unsupervised St. John's Wort in patients relying on stable inhaled controller therapy; discuss mood treatment alternatives with a clinician.
Search all 4 interaction records for Salmeterol/Fluticasone →
Numbered references. Citations throughout the page link here.
TORCH showed effects on exacerbations and health status with an observed increase in pneumonia in corticosteroid-containing arms.
SMART found increased asthma-related deaths with salmeterol added to usual care, especially when inhaled corticosteroid use was not assured.
Guidelines recommend anti-inflammatory controller therapy and caution against LABA monotherapy in asthma.
Labeling describes indications, twice-daily dosing, LABA precautions, pneumonia, candidiasis, adrenal, bone, and hypokalemia warnings.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
